The pneumococcal?polysaccharide vaccine is a vaccine that can protect against infections caused by a bacterium called Streptococcus pneumoniae.?This germ can lead to invasive diseases such as?otitis media?, pneumonia, meningitis and septicemia.
Vaccination consists of a mixture of polysaccharides for the seven most prevalent types of germs, and it works to stimulate the immune system to produce antibodies to these types of germs specifically, without causing disease.
This vaccine is intended for infants and children from 8 weeks old to 5 years old.
Unlike the Pneumovax vaccine, this vaccine is able to provide protection from opetococcosis in children under the age of two years.
This drug is included in the drug basket for people included in the increased risk groups for pneumococcal infection due to several conditions: malfunctioning of the spleen (eg splenectomy, congenital absence of the spleen and sickle cell anemia), immune disorders (due to malignancy, immunosuppressive therapies and infection with HIV) Acquired Immunodeficiency Virus (HIV).?Organ transplantation,?cerebrospinal fluid leak?with risk of recurring meningitis,?chronic kidney failure?, nephrotic syndrome, or dialysis treatment.

Trade name	Company name
SYNFLORIX VACCINE	GLAXOSMITHKLINE (GSK)

No File found

No File found

Gen name	Trade name	Catagory name
pneumococcal polysaccharide	SYNFLORIX VACCINE

Gen name

trade name

catogry